Ssl Biotech India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 9.19%
- Profit Growth 1.16%
- Ebitda 13.22%
- Net Worth 61.19%
- Total Assets 65.00%
About Ssl Biotech India
Ssl Biotech India Private Limited (SBIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 24 March 2014 and has a history of Ten years and ten months. Its registered office is in New Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Dharmendra Kumar, Santosh Barnwal, and Niraj Barnwal serve as directors at the Company.
Company Details
- Location
New Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media-
Corporate Identity Details
- CIN/LLPIN
U33119DL2014PTC266806
- Company No.
266806
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Mar 2014
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Ssl Biotech India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dharmendra Kumar  | Director | 10-Aug-2021 | Current |
| Santosh Barnwal | Director | 24-Mar-2014 | Current |
| Niraj Barnwal | Director | 24-Mar-2014 | Current |
Financial Performance of Ssl Biotech India.
Ssl Biotech India Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.19% increase. The company also saw a slight improvement in profitability, with a 1.16% increase in profit. The company's net worth Soared by an impressive increase of 61.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ssl Biotech India?
In 2023, Ssl Biotech India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Huro Fashion International Private LimitedSantosh Barnwal is a mutual person
- Gopsan Printing & Packaging Private Limited
Santosh Barnwal is a mutual person
- Parl Universal Private Limited
Santosh Barnwal is a mutual person
- Sunmax Industries India Limited
Santosh Barnwal is a mutual person
- Jangli Herbal & Foods Private Limited
Santosh Barnwal is a mutual person
- Prachin Herbal Private Limited
Santosh Barnwal is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Ssl Biotech India?
Unlock and access historical data on people associated with Ssl Biotech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ssl Biotech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ssl Biotech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
